Financial Ratios Hygeia Healthcare Holdings Co., Limited
Equities
6078
KYG4712E1035
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.55 HKD | -0.19% |
|
-8.66% | -15.06% |
| Mar. 30 | Hygeia Healthcare Holdings Co., Limited Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Mar. 30 | Hygeia Healthcare's Profit Slips in 2025 | MT |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 5.77 | 6.6 | 6.05 | 4.72 | 3.96 | ||||
Return on Total Capital | 6.54 | 7.7 | 7.15 | 5.55 | 4.57 | ||||
Return On Equity % | 10.28 | 10.23 | 12.24 | 9.26 | 2.4 | ||||
Return on Common Equity | 10.12 | 10.15 | 12.23 | 9.29 | 2.45 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 32.16 | 31.83 | 31.08 | 29.35 | 25.53 | ||||
SG&A Margin | 9.74 | 9.17 | 10.06 | 9.56 | 11.71 | ||||
EBITDA Margin % | 26.94 | 27.18 | 25.78 | 24.27 | 23.74 | ||||
EBITA Margin % | 22.88 | 23.18 | 21.49 | 18.57 | 17.25 | ||||
EBIT Margin % | 22.7 | 23.02 | 21.35 | 18.41 | 17.07 | ||||
Income From Continuing Operations Margin % | 19.57 | 15.08 | 16.8 | 13.46 | 4.03 | ||||
Net Income Margin % | 19.07 | 14.92 | 16.75 | 13.46 | 4.1 | ||||
Net Avail. For Common Margin % | 19.07 | 14.92 | 16.75 | 13.46 | 4.1 | ||||
Normalized Net Income Margin | 13.38 | 13.9 | 12.79 | 10.52 | 9.62 | ||||
Levered Free Cash Flow Margin | 1.33 | -6.35 | 3.9 | -2.22 | 8.52 | ||||
Unlevered Free Cash Flow Margin | 1.96 | -5.67 | 4.56 | -1.21 | 9.6 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.41 | 0.46 | 0.45 | 0.41 | 0.37 | ||||
Fixed Assets Turnover | 1.19 | 1.16 | 1.07 | 0.92 | 0.78 | ||||
Receivables Turnover (Average Receivables) | 6.4 | 6 | 5.45 | 5.14 | 5.18 | ||||
Inventory Turnover (Average Inventory) | 16.02 | 12.8 | 11.62 | 11.29 | 12.23 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 2.01 | 1.71 | 1.02 | 1.02 | 1.01 | ||||
Quick Ratio | 1.84 | 1.48 | 0.86 | 0.85 | 0.86 | ||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.67 | 0.4 | 0.39 | 0.56 | ||||
Days Sales Outstanding (Average Receivables) | 57.03 | 60.87 | 66.95 | 71.24 | 70.48 | ||||
Days Outstanding Inventory (Average Inventory) | 22.79 | 28.53 | 31.41 | 32.42 | 29.84 | ||||
Average Days Payable Outstanding | 47.29 | 57.24 | 68.53 | 72.07 | 70.77 | ||||
Cash Conversion Cycle (Average Days) | 32.53 | 32.16 | 29.83 | 31.58 | 29.54 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 27.51 | 26.1 | 43.56 | 41.82 | 36.05 | ||||
Total Debt / Total Capital | 21.57 | 20.69 | 30.34 | 29.49 | 26.5 | ||||
LT Debt/Equity | 26.73 | 22.39 | 37.11 | 33.8 | 29.51 | ||||
Long-Term Debt / Total Capital | 20.96 | 17.75 | 25.85 | 23.84 | 21.69 | ||||
Total Liabilities / Total Assets | 33.04 | 31.79 | 41.73 | 38.93 | 36.38 | ||||
EBIT / Interest Expense | 22.77 | 21.09 | 20.16 | 11.39 | 9.89 | ||||
EBITDA / Interest Expense | 27.54 | 25.31 | 24.79 | 15.32 | 14.09 | ||||
(EBITDA - Capex) / Interest Expense | -1.19 | 8.31 | 3.35 | 7.01 | 7.27 | ||||
Total Debt / EBITDA | 1.94 | 1.46 | 2.55 | 2.54 | 2.51 | ||||
Net Debt / EBITDA | 0.2 | 0.46 | 1.84 | 1.94 | 1.8 | ||||
Total Debt / (EBITDA - Capex) | -44.93 | 4.45 | 18.86 | 5.55 | 4.87 | ||||
Net Debt / (EBITDA - Capex) | -4.64 | 1.4 | 13.63 | 4.25 | 3.49 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 65.17 | 38.02 | 27.57 | 9.06 | -9.84 | ||||
Gross Profit, 1 Yr. Growth % | 57.78 | 36.58 | 24.56 | 3.02 | -23.02 | ||||
EBITDA, 1 Yr. Growth % | 61.84 | 39.25 | 21.01 | 2.96 | -12.63 | ||||
EBITA, 1 Yr. Growth % | 65.2 | 39.83 | 18.27 | -5.42 | -17.33 | ||||
EBIT, 1 Yr. Growth % | 65.22 | 39.98 | 18.29 | -5.62 | -17.48 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 155.96 | 6.33 | 42.14 | -12.65 | -73 | ||||
Net Income, 1 Yr. Growth % | 159.55 | 8 | 43.24 | -12.4 | -72.5 | ||||
Normalized Net Income, 1 Yr. Growth % | 92.15 | 43.33 | 17.38 | -9.97 | -18.52 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 86.84 | 8.45 | 40.26 | -12.04 | -71.98 | ||||
Accounts Receivable, 1 Yr. Growth % | 69.13 | 34.43 | 44.66 | -4.26 | -17.13 | ||||
Inventory, 1 Yr. Growth % | 128 | 49.76 | 36.87 | -0.9 | -23.76 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 84.29 | 19.14 | 54.41 | 9.69 | 2.64 | ||||
Total Assets, 1 Yr. Growth % | 42.24 | 8.3 | 48.23 | 1.81 | -2.42 | ||||
Tangible Book Value, 1 Yr. Growth % | -46.58 | 22.87 | -10.3 | 18.44 | 15.07 | ||||
Common Equity, 1 Yr. Growth % | 4.42 | 10.71 | 26.34 | 6.73 | 1.74 | ||||
Cash From Operations, 1 Yr. Growth % | 43.94 | 60.79 | 14.22 | -9.67 | 34.34 | ||||
Capital Expenditures, 1 Yr. Growth % | 106 | -10.55 | 56.07 | -35.44 | -21 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -117.61 | -757.97 | -178.37 | -162.91 | -469.91 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -131.2 | -500.15 | -202.7 | -129.32 | -911.33 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 46.03 | 50.99 | 32.69 | 17.95 | -0.84 | ||||
Gross Profit, 2 Yr. CAGR % | 50.19 | 46.8 | 30.43 | 13.28 | -10.12 | ||||
EBITDA, 2 Yr. CAGR % | 60.36 | 50.12 | 29.81 | 11.46 | -4.69 | ||||
EBITA, 2 Yr. CAGR % | 71 | 51.99 | 28.6 | 5.58 | -11.01 | ||||
EBIT, 2 Yr. CAGR % | 71.54 | 52.08 | 28.68 | 5.48 | -11.18 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 237.59 | 64.97 | 22.94 | 11.43 | -51.44 | ||||
Net Income, 2 Yr. CAGR % | 233.18 | 67.43 | 24.38 | 12.02 | -50.92 | ||||
Normalized Net Income, 2 Yr. CAGR % | 136.81 | 65.96 | 29.71 | 2.61 | -13.83 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 126.86 | 42.35 | 23.33 | 11.08 | -50.36 | ||||
Accounts Receivable, 2 Yr. CAGR % | 49.22 | 50.78 | 39.45 | 17.69 | -10.93 | ||||
Inventory, 2 Yr. CAGR % | 59.41 | 84.78 | 43.17 | 16.47 | -13.08 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 49.75 | 48.18 | 35.63 | 30.14 | 6.11 | ||||
Total Assets, 2 Yr. CAGR % | 73.82 | 24.11 | 26.7 | 22.85 | -0.32 | ||||
Tangible Book Value, 2 Yr. CAGR % | 87.82 | -18.98 | 4.98 | 3.08 | 16.74 | ||||
Common Equity, 2 Yr. CAGR % | 369 | 7.52 | 18.27 | 16.12 | 4.2 | ||||
Cash From Operations, 2 Yr. CAGR % | 36.55 | 52.13 | 35.52 | 1.57 | 10.16 | ||||
Capital Expenditures, 2 Yr. CAGR % | 107.34 | 35.74 | 18.15 | 0.38 | -28.59 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | -32.7 | 7.63 | 127.09 | -30.2 | 47.39 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 132.06 | 11.74 | 102.72 | -45.41 | 44.53 | ||||
Dividend Per Share, 2 Yr. CAGR % | - | 11.8 | - | - | - | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 44.58 | 43.31 | 42.74 | 24.3 | 7.85 | ||||
Gross Profit, 3 Yr. CAGR % | 46.6 | 45.51 | 38.98 | 20.57 | 0.21 | ||||
EBITDA, 3 Yr. CAGR % | 64.18 | 52.99 | 39.71 | 20.04 | 3.1 | ||||
EBITA, 3 Yr. CAGR % | 73.42 | 59.91 | 39.8 | 15.95 | -2.27 | ||||
EBIT, 3 Yr. CAGR % | 74.43 | 60.3 | 39.86 | 15.91 | -2.4 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 472.28 | 129.69 | 56.98 | 9.7 | -30.53 | ||||
Net Income, 3 Yr. CAGR % | 454.59 | 128.88 | 58.94 | 10.66 | -29.86 | ||||
Normalized Net Income, 3 Yr. CAGR % | 186.66 | 100.31 | 47.86 | 14.7 | -4.6 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 370.1 | 77.38 | 41.65 | 10.19 | -29.82 | ||||
Accounts Receivable, 3 Yr. CAGR % | 42.52 | 44.11 | 48.72 | 23.02 | 4.7 | ||||
Inventory, 3 Yr. CAGR % | 36.94 | 56.12 | 67.19 | 26.65 | 1.12 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 33.15 | 38.76 | 50.22 | 26.36 | 20.24 | ||||
Total Assets, 3 Yr. CAGR % | 49.97 | 48.46 | 31.68 | 17.79 | 13.77 | ||||
Tangible Book Value, 3 Yr. CAGR % | 53.37 | 63.04 | -16.19 | 9.29 | 6.93 | ||||
Common Equity, 3 Yr. CAGR % | 185.32 | 189.85 | 13.46 | 14.29 | 11.11 | ||||
Cash From Operations, 3 Yr. CAGR % | 38.64 | 44.19 | 38.27 | 18.38 | 11.5 | ||||
Capital Expenditures, 3 Yr. CAGR % | 32.1 | 56.67 | 42.21 | -3.41 | -7.33 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | -52.29 | 43.91 | -3.17 | 47.45 | 18.94 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -42.24 | 178.28 | 8.64 | 6.04 | 28.53 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 39.89 | 39.7 | 32.57 | 23.39 | ||||
Gross Profit, 5 Yr. CAGR % | - | 43.9 | 39.91 | 31.64 | 16.74 | ||||
EBITDA, 5 Yr. CAGR % | - | 63.75 | 49.45 | 34.79 | 19.82 | ||||
EBITA, 5 Yr. CAGR % | - | 78.31 | 53.87 | 35.44 | 16.61 | ||||
EBIT, 5 Yr. CAGR % | - | 80.34 | 54.45 | 35.59 | 16.55 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 59.62 | 209.34 | 71.98 | -1.82 | ||||
Net Income, 5 Yr. CAGR % | - | 59.33 | 204.99 | 71.98 | -0.66 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 83.34 | 108.74 | 53.29 | 19.05 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 35.51 | 175.26 | 47.09 | -6.87 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 38.72 | 41.29 | 32.9 | 21.15 | ||||
Inventory, 5 Yr. CAGR % | - | 38.47 | 39.4 | 38.85 | 28.7 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 30.51 | 34.14 | 35.25 | 30.72 | ||||
Total Assets, 5 Yr. CAGR % | - | 32.35 | 40.19 | 37.63 | 17.8 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 29.71 | 31.79 | 35.72 | -4.31 | ||||
Common Equity, 5 Yr. CAGR % | - | 74.3 | 100.61 | 101.03 | 9.66 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 59.29 | 37.39 | 25.34 | 26.25 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 20.94 | 26.33 | 31.11 | 7.96 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | -10.94 | 7.74 | 14.28 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | -4.56 | 45.05 | 21.53 |
Select your edition
All financial news and data tailored to specific country editions
















